Penethamate (Ubrostar)
Penethamate
Boehringer Ingelheim Animal Health South Africa (Pty) Ltd
Registration
- Applicant
- Boehringer Ingelheim Animal Health South Africa (Pty) Ltd
- Certificate holder
- Boehringer Ingelheim Animal Health South Africa (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ubrostar EACH 4,5 g SYRINGE CONTAINS BENETHAMINE PENICILLIN EQUIVALENT TO PENICILLIN 171,6 mg FRAMYCETIN SULPHATE EQUIVALENT TO FRAMYCETIN 71,0 mg PENETHAMATE HYDRIODIDE EQUIVALENT TO PENETHAMATE 77,2 mg | 77,2 mg. 171,6 mg. 71 mgIntramammary suspension | 17/0517/16.1/05Approved 23 August 2022 | Registered | Not determined | PI |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-(Diethylamino)ethyl (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Drag to rotate. Structure from PubChem CID 71797.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.